No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Abbott’s Amplatzer Piccolo Occluder Device Repairs Infant with an Opening in the Heart at St. Joseph’s Children’s Hospital in West Central Florida, 1st in the Region

Editor: What To Know

  • “Since the device is implanted through a minimally invasive procedure, many of the premature babies who are critically ill in the neonatal intensive care unit can be weaned from the breathing machine soon after the procedure,”.
  • The most common congenital heart defect occurring in premature babies, PDA occurs when a blood vessel in the fetal heart that is supposed to close after birth –.
  • Joseph’s Children’s Hospital is home to the Tampa Bay area’s only comprehensive congenital heart disease program, and its pediatric heart physicians perform hundreds of cardiac procedures each year to treat congenital and acquired heart conditions in children of any age, including newborns.

December 4, 2020

Abbott’s Amplatzer Piccolo Occluder Device is available at St. Joseph’s Hospital in West Central Florida.

The hospital notes infant Samantha Castellanos-Santana was delivered at 30 weeks gestation and was born with an opening in her heart, a condition known as patent ductus arteriosus. On Nov. 25, 2020, Samantha became the first patient in West Central Florida to have this type of heart defect repaired using Abbott’s Amplatzer Piccolo Occluder, a device smaller than a pea. St. Joseph’s Children’s Hospital is the region’s first hospital to use the Piccolo device, the only device U.S. FDA approved to close PDAs in premature babies.

“The Piccolo Occluder greatly increases our ability to close PDAs in the tiniest, most medically fragile babies, offering better options for patients who need corrective treatment and are high risk to undergo heart surgery,” said Dr. Jeremy Ringewald, a pediatric interventional cardiologist and the medical director of the Cardiac Catheterization Laboratory at St. Joseph’s Children’s Hospital in Tampa.

The most common congenital heart defect occurring in premature babies, PDA occurs when a blood vessel in the fetal heart that is supposed to close after birth – the ductus arteriosus – remains open. According to Dr. Ringewald, this opening is present in normally developing infants and typically closes spontaneously shortly after birth. Often in babies born prematurely, the PDA fails to close. This makes it difficult for babies to breathe normally due to increased blood flow to the lungs.

During Samantha’s procedure, Dr. Ringewald inserted a tiny catheter tube into a vein in the leg and guided the catheter into the PDA. He then advanced the self-expanding, wire mesh device through the catheter to spring open in the PDA, sealing it closed immediately.

“Since the device is implanted through a minimally invasive procedure, many of the premature babies who are critically ill in the neonatal intensive care unit can be weaned from the breathing machine soon after the procedure,” said Dr. Ringewald.

He adds that since patients do not outgrow the device after implantation, there is no need for additional procedures related to the PDA. Once the device is placed to seal the opening, it becomes part of the baby’s tissue, and is sealed for life.

St. Joseph’s Children’s Hospital is home to the Tampa Bay area’s only comprehensive congenital heart disease program, and its pediatric heart physicians perform hundreds of cardiac procedures each year to treat congenital and acquired heart conditions in children of any age, including newborns. A partnership between St. Joseph’s Children’s Hospital and the Children’s Hospital of Pittsburgh of UPMC provides families across Florida with unprecedented access to the highest level of pediatric heart care available. Together, they provide highly specialized cardiovascular care for patients ranging from babies in the womb to adults with congenital heart disease.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy